JP2004533246A5 - - Google Patents

Download PDF

Info

Publication number
JP2004533246A5
JP2004533246A5 JP2002587611A JP2002587611A JP2004533246A5 JP 2004533246 A5 JP2004533246 A5 JP 2004533246A5 JP 2002587611 A JP2002587611 A JP 2002587611A JP 2002587611 A JP2002587611 A JP 2002587611A JP 2004533246 A5 JP2004533246 A5 JP 2004533246A5
Authority
JP
Japan
Prior art keywords
lactococcus
strain
gene
transformed strain
transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002587611A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004533246A (ja
JP4347575B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/004942 external-priority patent/WO2002090551A2/en
Publication of JP2004533246A publication Critical patent/JP2004533246A/ja
Publication of JP2004533246A5 publication Critical patent/JP2004533246A5/ja
Application granted granted Critical
Publication of JP4347575B2 publication Critical patent/JP4347575B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002587611A 2001-05-03 2002-05-03 自己自制ラクトコッカス(Loctococcus)株 Expired - Fee Related JP4347575B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01201631 2001-05-03
EP01204785 2001-12-07
PCT/EP2002/004942 WO2002090551A2 (en) 2001-05-03 2002-05-03 Self-containing lactococcus strain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008260591A Division JP2009060913A (ja) 2001-05-03 2008-10-07 自己自制ラクトコッカス(Loctococcus)株

Publications (3)

Publication Number Publication Date
JP2004533246A JP2004533246A (ja) 2004-11-04
JP2004533246A5 true JP2004533246A5 (enExample) 2005-12-22
JP4347575B2 JP4347575B2 (ja) 2009-10-21

Family

ID=26076897

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002587611A Expired - Fee Related JP4347575B2 (ja) 2001-05-03 2002-05-03 自己自制ラクトコッカス(Loctococcus)株
JP2008260591A Withdrawn JP2009060913A (ja) 2001-05-03 2008-10-07 自己自制ラクトコッカス(Loctococcus)株

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008260591A Withdrawn JP2009060913A (ja) 2001-05-03 2008-10-07 自己自制ラクトコッカス(Loctococcus)株

Country Status (9)

Country Link
EP (1) EP1383897B1 (enExample)
JP (2) JP4347575B2 (enExample)
AT (1) ATE331789T1 (enExample)
AU (1) AU2002314040B2 (enExample)
CA (1) CA2446776C (enExample)
DE (1) DE60212825T2 (enExample)
DK (1) DK1383897T3 (enExample)
ES (1) ES2266515T3 (enExample)
WO (1) WO2002090551A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
DE60319822T2 (de) 2002-06-19 2009-06-04 Actogenix Nv Verfahren und mittel zur erhöhung der darmabsorption
WO2004056850A2 (en) * 2002-12-19 2004-07-08 Vib Vzw Mutant proteins showing increased secretion
JP4589618B2 (ja) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
WO2006018446A2 (en) * 2004-08-20 2006-02-23 Actogenix Nv Method to improve lactococcus preservation
DK2119450T3 (da) * 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
CA2672229A1 (en) * 2006-12-14 2008-06-19 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
CN101605900B (zh) * 2007-01-12 2014-04-23 阿克图杰尼斯公司 乳球菌启动子和其用途
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
JP2012504116A (ja) * 2008-09-29 2012-02-16 アクトジェニックス・エヌブイ 粘膜での微生物のコロニー形成の低減
EP2714912B1 (en) 2011-06-01 2018-05-02 Intrexon Actobiotics NV Polycistronic expression system for bacteria
HUE038830T2 (hu) 2011-09-23 2018-11-28 Intrexon Actobiotics Nv Módosított gram-pozitív baktériumok és alkalmazásaik
CN103917639B (zh) 2011-09-23 2017-09-26 英特瑞克斯顿阿克图比奥帝克斯有限公司 经修饰的革兰氏阳性细菌及其用途
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
KR20170121291A (ko) * 2015-03-02 2017-11-01 신로직 인코포레이티드 감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아
CN106148254B (zh) * 2015-03-26 2019-11-12 南京华贞生物医药科技有限公司 一种用于减肥降脂的转化体及其构建方法与应用
EP3882259B1 (en) 2015-05-13 2026-01-28 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
JP6993970B2 (ja) 2015-11-16 2022-02-15 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を低減させるように操作された細菌
JP7292877B2 (ja) 2016-01-14 2023-06-19 イントレクソン・アクトバイオテイクス・エヌブイ 1型糖尿病を処置するための組成物および方法
US10858663B2 (en) 2016-09-02 2020-12-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing IL-10 and insulin
KR102469701B1 (ko) 2016-09-13 2022-11-22 인트랙슨 액토바이오틱스 엔.브이. 점막부착성 미생물
EP3642221A1 (en) 2017-06-21 2020-04-29 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
EP3864048A1 (en) 2018-10-11 2021-08-18 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Bacteria expressing single chain antibodies against toll-like receptors
CA3156035A1 (en) 2019-09-27 2021-04-01 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
WO2021188819A1 (en) 2020-03-20 2021-09-23 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4231764A1 (de) * 1992-09-23 1994-03-24 Inst Pflanzengenetik & Kultur Verfahren zur chromosomalen Integration eines Produkt-Gens

Similar Documents

Publication Publication Date Title
CA2446776A1 (en) Self-containing lactococcus strain
CN102906105B (zh) 肽及其用途
KR20250114110A (ko) 약물 활성의 조절제로서의 부프로피온
JP2011500073A5 (enExample)
JP2003531157A5 (enExample)
JP2009541479A5 (enExample)
JP2005237328A5 (enExample)
JP2007526248A5 (enExample)
WO2008101907A3 (en) N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
JP2012532874A5 (enExample)
WO2007009539A3 (en) Use of inhibitors of histone deacetylases in combination with nsaid for the therapy of cancer and/or inflammatory diseases
JP2008536483A5 (enExample)
WO2007144394A3 (en) Pharmaceutical use of substituted piperidine carboxamides
EP1529527A3 (en) Valproic acid for a combination treatment of human cancers, tumor metastasis and minimal residual disease
JP2006522006A5 (enExample)
JP2011524850A5 (enExample)
JP2020193206A5 (enExample)
JP2008541759A5 (enExample)
JP2010534236A5 (enExample)
JP2017222722A5 (enExample)
JP2009535328A5 (enExample)
JP2016517446A5 (enExample)
JP2008538288A5 (enExample)
JP2005508872A5 (enExample)
JP2010500284A5 (enExample)